-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRA PHARMACEUTICALS - SUBMITS PHASE 2A PROTOCOL FOR KETAMIR-2 IN CIPN TO IRB AFTER FDA REVIEW

Reuters·09/17/2026 12:30:02

Please log in to view news